IGC (IGC Pharma) Tax Rate %: 0.00% (As of Mar. 2026)

What is IGC Pharma Tax Rate %?

IGC Pharma IGC -2.51% 29 Tax Rate % is 0.00% as of Mar. 2026. GuruFocus rates IGC with a GF Score™ of 29/100 and a GF Value™ of $0.24 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. IGC Pharma's Tax Expense for the three months ended in Mar. 2026 was $0.00 Mil. IGC Pharma's Pre-Tax Income for the three months ended in Mar. 2026 was $-2.40 Mil. Therefore, IGC Pharma's Tax Rate % for the quarter that ended in Mar. 2026 was 0.00%.

IGC Pharma Tax Rate % Related Terms

IGC Pharma Tax Rate % Historical Data

* Premium members only.

The historical data trend for IGC Pharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IGC Pharma Tax Rate % Chart

IGC Pharma Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Tax Rate %

Get a 7-Day Free Trial

0.00

IGC Pharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Tax Rate %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

29GF Score

IGC Pharma Inc IGC

Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

IGC Pharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

IGC Pharma's Tax Rate % for the fiscal year that ended in Mar. 2025 is calculated as

Tax Rate %	=	Tax Expense (A: Mar. 2025 )	/	Pre-Tax Income (A: Mar. 2025 )
	=	0	/	-7.121
	=	0.00 %

IGC Pharma's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2026 )	/	Pre-Tax Income (Q: Mar. 2026 )
	=	0	/	-2.402
	=	0.00 %

Frequently Asked Questions Learn more about Tax Rate % →

What does a Tax Rate % of 0.00% mean?

IGC Pharma (IGC) has a Tax Rate % of 0.00% as of Mar. 2026.

Is IGC Pharma's Tax Rate % too high?

IGC Pharma's current Tax Rate % is 0.00%. Overall, IGC Pharma has a GF Score™ of 29/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does IGC Pharma's Tax Rate % compare to SER and NRSN?

IGC Pharma's Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Tax Rate % for a Biotechnology company?

A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Tax Rate % mean?

A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. IGC Pharma's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is IGC Pharma stock overvalued right now?

Based on GuruFocus' analysis, IGC Pharma (IGC) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.24, compared to a current price of $0.27 — trading 13.3% above its estimated fair value. The current Tax Rate % is 0.00%. IGC Pharma's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Tax Rate % calculated?

Tax Rate % is calculated from a company's financial statements. For IGC Pharma (IGC), the current Tax Rate % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IGC Pharma (IGC) Overvalued in 2026?

Based on GuruFocus' analysis, IGC Pharma stock appears to be overvalued. The current stock price of $0.27 is trading 13.3% above its estimated GF Value™ of $0.24. GuruFocus considers IGC Pharma to be Modestly Overvalued.

Key valuation signals for IGC:

Tax Rate %: 0.00%
GF Value™: $0.24 vs. price of $0.27 (13.3% above fair value)
GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the IGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IGC Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies SER NRSN PVCT NEUP PLRZ SKYE VTGN PSTV KYNB TVGN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges IGS1:Germany

Address 10224 Falls Road, Potomac, MD, USA, 20854

Website https://www.igcinc.us

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

29GF Score

Get the complete analysis for IGC

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27

Price

$0.24

GF Value

View IGC Analysis

See Tax Rate % data for all stocks →